1. EcTI impairs survival and proliferation pathways in triple-negative breast cancer by modulating cell-glycosaminoglycans and inflammatory cytokines. (28th October 2020) Authors: Lobo, Yara A.; Bonazza, Camila; Batista, Fabrício P.; Castro, Rodrigo A.; Bonturi, Camila R.; Salu, Bruno R.; de Cassia Sinigaglia, Rita; Toma, Leny; Vicente, Carolina M.; Pidde, Giselle; Tambourgi, Denise V.; Alvarez-Flores, Miryam P.; Chudzinski-Tavassi, Ana M.; Oliva, Maria Luiza V. Journal: Cancer letters Issue: Volume 491(2020) Page Start: 108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗